Ratings by Wedbush
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 8/24/2026 | Seth Basham | Best Buy | BBY | Maintain | Neutral (N/A) |
85.00 (75.00) |
|
Details | |
| 8/19/2026 | David Nierengarten | Aktis Oncology | AKTS | New Coverage | Outperform (N/A) |
35.00 (N/A) |
25.00 (25.99) |
3.96% | Details |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 8,824 more... | |||||||||
